The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

These include commonly prescribed drugs such as Ozempic or Wegovy (semaglutide), Saxenda (liraglutide), Zepbound (tirzepatide ... and reported better physical functioning. Ozempic and Wegovy ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now. By Rebecca Robbins It’s easy to make a medical case for ...

and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) have shown experimentally what has been speculated via indirect comparisons for some time – Zepbound is better at helping patients shed weight.

And on Wednesday the maker of Wegovy, a similar weight-loss drug, announced that it, too, would offer direct-to-consumer discounts for patients paying cash. The drugs usually come as autoinjector pens ...

Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U ...

Last year, around 200,000 prescriptions for copies of Novo Nordisk’s weight-loss drug Wegovy alone were being filled each month. But now, the makers of the original versions of the drugs say ...

Insurance coverage for GLP-1 drugs remains tight despite rising demand, with more patients facing restrictions or paying out of pocket, GoodRx said.

Last week, Eli Lilly, the maker of Zepbound, also cut prices for its starter dose to $349 per month. Larger doses will now cost $499 per month through the company’s self-pay program.

Makers of Wegovy & Zepbound Cut Prices for Those Without Insurance FRIDAY, March 7, 2025 (HealthDay News) -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting ...